Structured Abstract
BACKGROUND Diabetes mellitus DM (type 2) is one of the major chronic disease that creates burden at the population level. A prevalence of 422 million patients with diabetes worldwide is detected 1. UAE population has an increased prevalence of DM; According to International Diabetes Federation (IDF) 17.3% of the UAE population between the ages of 20 and 79 have type 2 diabetes in 2017 2. UAE has been suffering with the health problems that result from obesity and sedentary lifestyle. The purpose of this study is to understand barriers to health behavior among community patients with diabetes mellitus type 2. METHODS: This is a qualitative survey study of 123 adult individuals with type 2 diabetes who are above 18 years old, who participated in a survey that explore their perception about barriers to health behavior change. The survey was distributed online and in 6 health care centers under ministry of health and prevention in the United Arab Emirates. RESULTS: This study finds that the top barrier for behavior change is difficulty to follow healthy schedule (19.4%), workplace condition and timing (14.3%), and laziness (13%). The least barrier was lack of knowledge about healthier behaviors (5.3%). The best way to motivate behavior change was doctor’s advice during regular visit (26.3%), joining support group (18.4%), and receiving electronic tips and reminders on smartphones (15%) CONCLUSION: The outcomes of this study can aid directly in community programs design and implementation, health education campaigns, and health policies. The findings of this study help in understanding real barriers to initiating and sustaining positive health behavior.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
no funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research has undergone Institutional Review Board IRB process from two committees: MOHAP research ethics committee in UAE and IRB in Arizona State University ASU, USA. MOHAP research ethics committee had approved the study protocol to be conducted (Reference no.: MOHAP/DB-REC/MJJ/No.20/2019). The study was exemption granted from IRB in Arizona State University (IRB ID: STUDY00010026). The IRB determined that the protocol is considered exempt pursuant to Federal Regulations 45CFR46 (2) Tests, surveys, interviews, or observation on 4/23/2019.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All Mentioned Data is available
